Influenza A/H1/N1/09 infection in patients with cirrhosis has a poor outcome: A case series

Indian Journal of Gastroenterology

Volumn 33, Issue 2, 2014, Pages 178-182

  Bal, Chinmaya Kumar ^a   Bhatia, Vikram ^a   Kumar, Sachin ^a   Saini, Deepak ^a   Khillan, Vikas ^a   Gupta, Ekta ^a   Rathor, Neha ^a   Choudhury, Ashok ^a   Kumar, Naveen ^a   Daman, Ripu ^a   Sarin, Shiv Kumar ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

H1N1 subtype; Influenza A virus; Liver; Swine flu

Indexed keywords

ANTIBIOTIC AGENT; OSELTAMIVIR; ANTIVIRUS AGENT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BACILLI; CASE REPORT; DEATH; FEMALE; HEPATITIS C; HUMAN; JAUNDICE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; RESPIRATION DEPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SURVIVAL; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; TREATMENT OUTCOME; VIRUS VIRULENCE; ADOLESCENT; AGED; COMPLICATION; DISEASE COURSE; FATALITY; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OSELTAMIVIR; YOUNG ADULT;

EID: 84897375914     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-014-0443-5     Document Type: Article

References (14)

1. http://www. cdc. gov/flu/keyfacts. htm. Accessed on 22 May 2013.
2. Panning M, Eickmann M, Landt O, et al. Detection of influenza A(H1N1)v virus by real-time RT-PCR. Euro Surveill. 2009;14(36): 19329.
3. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic decompensation in patients with cirrhosis during infection with influenza A. Arch Intern Med. 2000;160: 113-5.
4. Marzano A, Marengo A, Ruggiero T, et al. Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: experience from a nosocomial cluster of infection. J Med Virol. 2013;85: 1-7.
5. Ledesma J, Pozo F, Pérez Ruiz M, et al. Substitutions in position 222 of haemagglutinin of pandemic influenza A (H1N1) 2009 viruses in Spain. J Clin Virol. 2011;51: 75-8.
6. Puzelli S, Facchini M, Spagnolo D, et al. Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis. 2010;16: 863-5.
7. Kilander A, Rykkvin R, Dudman SG, Hungnes O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010;15(9): 19498.
8. Rykkvin R, Kilander A, Dudman SG, Hungnes O. Within-patient emergence of the influenza A(H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway. Euro Surveill. 2013;18: 20369.
9. Song JY, Cheong HJ, Ha SH, et al. Clinical impact of influenza immunization in patients with liver cirrhosis. J Clin Virol. 2007;39: 159-63.
10. Pirakalathanan J, Lau KK, Joosten SA. Chest radiographic appearances in adult inpatients admitted with swine flu infection: local experience in Melbourne. J Med Imaging Radiat Oncol. 2013;57: 50-6.
11. Bakhshayeshkaram M, Saidi B, Tabarsi P, Zahirifard S, Ghofrani M. Imaging findings in patients with H1N1 influenza A infection. Iran J Radiol. 2011;8: 230-4.
12. Leise MD, Talwalkar JA. Immunizations in chronic liver disease: what should be done and what is the evidence. Curr Gastroenterol Rep. 2013;15: 300.
13. Gaeta GB, Pariani E, Amendola A, et al. Influenza vaccination in patients with cirrhosis and in liver transplant recipients. Vaccine. 2009;27: 3373-5.
14. Loulergue P, Pol S, Mallet V, Sogni P, Launay O, GEVACCIM Group. Why actively promote vaccination in patients with cirrhosis? J Clin Virol. 2009;46: 206-9.